GlassScriptPhysician profile
John J Finley
NPI 1750360020
$22,503.15
in general payments reported to CMS, 2019-2025
40 companies · $9,641 in 2025
The $9,641 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,108 · 2020: $818 · 2021: $3,629 · 2022: $1,902 · 2023: $1,810 · 2024: $2,595 · 2025: $9,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,850 · Food and Beverage: $5,397 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,849.60 |
| Food and Beverage | $5,396.60 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,488.86 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Ffrangio |
| Inari Medical, INC. | $2,495.13 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cagent Vascular INC | $1,942.30 | 2021-2024 | Serrantor |
| Abiomed | $1,414.14 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $746.27 | 2021-2024 | Xarelto |
| Abbott Laboratories | $559.38 | 2019-2023 | Xience Skypoint, Cardiomems, Diamondback Peripheral |
| Shockwave Medical, INC | $537.49 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $517.89 | 2020-2025 | Farxiga, Brilinta |
| Amgen INC. | $489.06 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $414.84 | 2019-2023 | |
| Medtronic Vascular, INC. | $414.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $387.74 | 2020-2025 | |
| Heartflow, INC. | $363.10 | 2023-2024 | Ffrct |
| Getinge USA Sales, LLC | $347.17 | 2019-2021 | |
| Boston Scientific Corporation | $305.55 | 2019-2025 | Resonate El Icd Vr, Eluvia, Rotapro |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $240.39 | 2019-2025 | Eliquis, Camzyos |
| Cook Medical LLC | $207.60 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.40 | 2019-2025 | Lifevest |
| Livanova USA, INC. | $158.25 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $140.26 | 2019-2023 | Venclose Maven Catheter |
| Novo Nordisk INC | $138.26 | 2025 | Wegovy, Rybelsus, Ozempic |
| Penumbra, INC. | $125.00 | 2021 | |
| Stryker Corporation | $124.82 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Asahi Intecc USA, INC. | $108.70 | 2019-2020 | |
| Amarin Pharma, INC. | $83.66 | 2019-2022 | |
| Biotronik INC. | $78.47 | 2019-2022 | |
| Cordis US Corp. | $62.05 | 2023 | Mynx Control, Saber |
| Impulse Dynamics (USA) INC. | $56.05 | 2021-2022 | |
| Reflow Medical INC | $53.30 | 2024-2025 | |
| Esperion Therapeutics, INC. | $53.10 | 2023 | Nexletol |
| Kestra Medical Technology Services, INC. | $47.96 | 2025 | Assure Wcd |
| Philips North America LLC | $45.91 | 2019-2021 | |
| Surmodics, INC. | $38.76 | 2023-2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Pfizer INC. | $32.27 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.75 | 2023 | Jardiance |
| Angiodynamics, INC. | $28.46 | 2025 | Auryon Laser System 100-120 Vac |
| Alnylam Pharmaceuticals INC. | $22.45 | 2023 | Amvuttra |
| Terumo Medical Corporation | $15.42 | 2020 | |
| Scpharmaceuticals INC. | $13.40 | 2024 | |
| Dentsply Sirona INC | $12.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Finley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.